Oncolytics Biotech Inc. (ONCY)

[onco_investor]

EORTC Abstracts Listed - Panc and PhII H&N

Abstracts are now available online

http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=dbdc0b09-936f-4d6a-9c0a-756e0cd55f51&cKey=e39c6e23-bc11-43d2-8d42-e12eef71f226&mKey={A57FF86D-D414-4079-BCBD-157746574F37}

B55 - A Study of REOLYSIN in Combination with Gemcitabine in Patients with Advanced Pancreatic Adenocarcinoma

Monica M. Mita1, Yubao Wang2, John Sarantopoulos1, Sushma Vemulapalli1, Benjamin George3, Alain Mita1, Mattew Coffey4, George Gill5, Devaligam Mahaligam1. 1Cancer Therapy and Research Center at UTHSCSA, San Antonio, TX; 2Cancer Therapy and Reserach Center, San Antonio, TX; 3Brooke Army Medical Center, San Antonio, TX; 4Oncolytics Biothech, Calgary, AB, Canada; 5Oncolytics Biotech, Calgary, AB,

Canada Poster Session
PO.18. Clinical Trials 2
Mon, Nov 14, 12:30 - 2:30 PM


Also US Phase II H&N at
http://www.abstractsonline.com/Plan/ViewAbstract.aspx?sKey=3689430c-4df3-4d0e-a34c-692c209b1f10&cKey=da6a20b4-0498-4900-9466-057b7e45c07d&mKey={A57FF86D-D414-4079-BCBD-157746574F37}


Presentation Abstract

C22
A phase II study of intravenous wild-type reovirus (Reolysin®) in combination with paclitaxel plus carboplatin in patients with platinum refractory metastatic and/or recurrent squamous cell carcinoma of the head and neck

West Hall, Level One, Moscone Center West

Poster Board Number: C22

Anand B. Karnad1, Missak Haigentz2, Tracy Miley1, Matt Coffey3, George Gill3, Monica Mita1. 1CTRC, UT Health Science Center, San Antonio, TX; 2Montefiore Medical Center, Bronx, NY; 3Oncolytics Biotech Inc., Calgary, AB, Canada